1.
Eur J Haematol
; 110(2): 209-212, 2023 Feb.
Article
in English
| MEDLINE
| ID: mdl-36208028
ABSTRACT
XLA patient with 7-month course of COVID-19 with persistent plasma SARS-CoV-2 load revealed a sustained non-inflammatory profile of myeloid cells in association with contained severity of disease, arguing in favor of the use of BTK inhibitors in SARS-COV-2 infection.